ClinicalTrials.Veeva

Menu
C

CenExel Clinical Research | Anaheim Clinical Trials

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

PF-06882961
Risankizumab
VX-548
LY3502970
PF-06700841
PF-07081532
PF-06291874
Maridebart Cafraglutide
Buprenorphine
Midazolam

Parent organization

This site is a part of CenExel Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

21 of 234 total trials

A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity

The purpose of this study is to evaluate how well eloralintide and eloralintide with tirzepatide is tolerated and what side effects may occur in part...

Active, not recruiting
Overweight
Obesity
Drug: Eloralintide and Tirzepatide
Drug: Eloralintide

The purpose of this study is to evaluate how well LY3867070 is tolerated and what side effects may occur in healthy participants. The study drug will...

Enrolling
Healthy
Drug: LY3867070
Drug: Placebo

The main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM)
Drug: Maridebart Cafraglutide
Drug: Placebo

This two-part study will evaluate the bioequivalence, safety, and tolerability of a single SC dose of trastuzumab administered via handheld syringe/s...

Enrolling
Healthy Participants
Drug: Trastuzumab

The purpose of this study is to assess the safety, tolerability, and pharmacokinetics (PK) of multiple doses of KarXT + KarX-EC capsules versus KarXT...

Enrolling
Healthy Volunteers
Drug: Placebo
Drug: Omeprazole

The purpose of this study is to evaluate the safety, pharmacokinetics, and pharmacodynamics of multiple doses of VIS954 compared with placebo in heal...

Active, not recruiting
Healthy
Drug: VIS954
Drug: Placebo

The purpose of this study is to evaluate the pharmacokinetics (PK) of xanomeline following administration of KarXT in CYP2D6 normal/extensive, interm...

Enrolling
Healthy Volunteers
Drug: Xanomeline/ Trospium Chloride
Status recently updated

The primary objective of this study is to evaluate the effect of a meal and evening dosing on the pharmacokinetics (PK) of KAI 7535 in healthy partic...

Not yet enrolling
Enrolling
Overweight
Obesity
Drug: KAI-7535

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a...

Enrolling
COVID-19
SARS-COV-2 Infection
Biological: Placebo
Biological: BNT162b2 Vaccine

This study evaluates an investigational vaccine designed to protect against Escherichia coli (E coli). The primary objective is to assess the safety...

Enrolling
Healthy Participants
Drug: E coli Vaccine 4 Dose C
Drug: E coli vaccine 3

The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together.This study is seeking healthy...

Active, not recruiting
COVID-19 (Coronavirus Disease 2019)
Influenza
Biological: Licensed Influenza Vaccine 2
Biological: Licensed Influenza Vaccine 1

The purpose of the study is to learn how the study medicine called PF-07868489 is tolerated and acts in healthy adult people and people with pulmonar...

Enrolling
Pulmonary Arterial Hypertension
Drug: Placebo for PF-07868489
Drug: PF-07868489

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07976016) for the potential treatment of...

Active, not recruiting
Obesity
Drug: PF-07976016
Drug: Placebo

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (...

Active, not recruiting
Obesity
Drug: Matching Placebo-Trevogrumab
Drug: Matching Placebo-Garetosmab

The main objective of this trial is to evaluate the pharmacokinetics (PK) of maridebart cafraglutide administered as a single dose using two differen...

Enrolling
Overweight and Obesity
Drug: Maridebart Cafraglutide

The main objective of this trial is to evaluate the pharmacokinetics (PK) of maridebart cafraglutide administered as a single dose using two differen...

Enrolling
Overweight
Obesity
Drug: Maridebart Cafraglutide

The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of escalating single and repeat doses of PF-07832837 in health...

Enrolling
Atopic Dermatitis
Healthy Participants
Other: Placebo
Drug: PF-07832837

A Phase 1, Open-Label Study to Assess Pharmacokinetics, Safety and Tolerability of G1090N in Healthy Subjects

Enrolling
Acute-on-Chronic Liver Failure
Drug: Multiple dosing of G1090N
Drug: Single Dose G1090N

Researchers are looking for new ways to prevent cancers related to human papillomavirus (HPV). HPV is a common virus that can cause an infection. The...

Active, not recruiting
Healthy
Biological: V540B
Biological: GARDASIL®9 (G9)

The primary objective of this study is to assess the safety and tolerability of AMG 513 after single and multiple doses.

Enrolling
Cardiometabolic Disease
Drug: Placebo
Drug: AMG 513

Trial sponsors

Pfizer logo
Lilly logo
Bristol-Myers Squibb (BMS) logo
AbbVie logo
Amgen logo
BioNTech logo
Vertex Pharmaceuticals logo
Celgene logo
H
Novavax logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems